Topic Podcasts - PsA Part3

Save

Sunday (Day 2): ACR 22 Daily Recap

Topic Podcasts - PsA Part2

Save

ACR 2022 Appraisal, Praise & Critique (11.18.2022) Best of ACR Day Two in PSA Efficacy and Safety Results from BE OPTIMAL in PsA JAK inhibitors in rheumatic diseases Oligoarticular PsA: FOREMOST Study Opioid use in PsA and SpA PET CT Imaging to Define Risk of Progression from PSO to PsA PsA and SPA: Cyclers, Switchers, Who is the Winner? Switch

Topic Podcasts - PsA Part1

Save

Best of PsA on Day 1 Can computers tell the difference between RA & PsA? Deucravacitinib in PsA Differences in Presentation and Outcomes of Early vs Late Onset PsA Opioids and Health Care Utilization in PsA and AS Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor PsA Cycling or Switching MOAs The Dietary Intervention in PsA (DIPSA)

Topic Podcasts - RA Part4

Save

Sunday (Day 2): ACR 22 Daily Recap

Topic Podcasts - RA Part3

Save

Bouncebackability portends increased risk of adverse outcomes in RA Can I stop Methotrexate in RA? Fat and bone are never alone: osteoporotic fracture in RA JAK inhibitors in rheumatic diseases RA: Steroids are bad, again Reproductive health in a post-Roe world Sensor-engineered glove evaluates hand function in RA Tapering Methotrexate with Biologi

Topic Podcasts - RA Part2

Save

ACR22 Daily Recap: Saturday Recap JAK vs TNF inhibitor Infections in RA Opioid and Neuropathic Use After Initiating btsDMARDs in RA Pre-RA Pharmacological Interventions: Delaying is not Enough PreRA to Treat or Not! Prescribing Methotrexate in Post-Roe Era The Great Debate: To Treat or Not to Treat Pre RA To Switch or Not: Biosimilars in Inflammato

Topic Podcasts - RA Part1

Save

ACR22 Year in Review Report Can computers tell the difference between RA & PsA? NSAIDs and CV risk in Inflammatory Arthritis Prelude to a Meeting (ACR22) (11.11.2022) QD205 - RA Activity During Pregnancy (abstract #0955) Sputum anti-CCP the new diagnostic test in at-risk RA? Switching Between JAK Inhibiters in RA Treatment Choices and Mortality

Topic Podcasts ACR2022 - SpA Part4

Save

Treatment Considerations in Axial Spondyloarthritis What Happens after you stop biologics? What lifestyle factors affect TNF inhibitor efficacy in AxSpA? Which is better for AxSpA? IL-17i or TNFi? Women vs. Men: Response to Treatment in Seronegative Arthritis

Topic Podcasts ACR2022 - SpA Part3

Save

Opioids and Health Care Utilization in PsA and AS Reproductive health in a post-Roe world Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression Sunday (Day 2): ACR 22 Daily Recap Tapering TNFi in nonradiographic AxSpA The CONSUL Trial: Ankylosing Spondylitis

Topic Podcasts ACR2022 - SpA Part2

Save

Comorbidities in Ankylosing Spondylitis Early Diagnosis of Axial Spondyloarthritis Fertility issues in SpA Gender in AxSpa Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE JAK inhibitors in rheumatic diseases Opioid use in PsA and SpA

Topic Podcasts ACR2022 - SpA Part1

Save

ACR22 Daily Recap: Saturday Recap AI Future of Sacroiliitis Assessment Artificial Intelligence in Detecting Sacroiliitis Axial Spondyloarthritis: gender differences Can we alter neonatal gut microbiome to prevent spondyloarthritis? Comorbidities in Axial Spondyloarthritis Do Disease Activity Measures Really Capture AS in Women?

RheumNow Rheumatology Roundup

Save

Dr. Jack Cush and Dr. Arthur Kavanaugh discuss, dissect and deliberate the sessions and data presented at the ACR22 meeting in Philadelphia.